Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced today that data from a laboratory study evaluating the ultraviolet A light used in the Healight™ endotracheal catheter technology was published in the peer reviewed journal Photodiagnosis and Photodynamics Therapy.“These latest in vitro findings continue to build upon the body…
Aytu BioPharma Announces Publication of Data Demonstrating Ultraviolet-A Light Reduces Cellular Cytokine Release from Human Endotracheal Cells Infected with Coronavirus
More from InformationalMore posts in Informational »
- Malaysia Hospital Efforts To Lead Green Revolution Include Use Of UVGI Disinfection Technology
- Far-UVC Light Impacts DNA Of Lung Cells and Tissue
- UV Business News – BIO-UV Alliance With Innovasea Proving Successful
- UV Business News – Atlantic Ultraviolet Launches Disinfection Cabinet With Multiple Industry Applications
- Germicidal UV Tourted As One Solution For Bird Flu Preparedness In Schools